You are here

Solutions

Medical charity MSF opens Ebola clinic for pregnant women

REUTERS  BY Umaru Fofana                                                                        Jan. 10, 2015

FREETOWN --Medical charity Medicins Sans Frontiers (MSF) has opened the first care center in the current Ebola epidemic for pregnant women, whose survival rate from the virus is virtually zero, the charity said on Saturday....

An Ebola virus treatment center is seen in Bo, Sierra Leone, November 17, 2014. Credit: Reuters/Benjamin Black

There is currently one patient in the clinic, which is perched on a hill in the compound of a disused Methodist boys high school in the Sierra Leone capital.

Women are particularly vulnerable to a disease spread through direct contact with infected people and with the corpses of victims, because women often care for sick family members, said MSF Field Coordinator, Esperanza Santos.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EbolaTracks: an automated SMS system for monitoring persons potentially exposed to Ebola virus disease

EUROSURVEILLANCE                                                              Volume 20, Issue 1, Jan. 8 2015

Australian researchers reported on an automated text-message system used for actively monitoring people potentially exposed to Ebola. The system prompts contacts to submit information on symptoms and temperature twice a day. The Department of Health in Western Australia uses the system, called "EbolaTracks," to track travelers returning from West Africa and (potentially) contacts of any local cases.

Twenty-two people were enrolled in the program as of Jan 5, and 14 have completed active monitoring. The system sent 1,108 text messages and got a 91% response rate. Health officials followed up by phone when they didn't get a reply. Such systems could be valuable tools for larger-scale contact monitoring for Ebola or other infectious diseases, they concluded.

http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20999

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola: Suitcase kit detects virus in 15 minutes, as vaccine testing nears final stages

INTERNATIONAL BUSINESS TIMES  by                  Jan. 15, 2015

Researchers at DPZ, Germany, have developed a simple Ebola diagnostics kit that detects the virus in 15 minutes, without requiring any electricity, cold chain or lab equipment.

Infection researcher Dr Ahmed Abd El Wahed and the head of the Unit of Infection Models at the German Primate Center (DPZ), Dr med. vet. Christiane Stahl-Hennig, present the ebola suitcase laboratory Abd El Wahed invented.Karin Tilch, DPZ

The diagnostics-in-a-suitcase that comes equipped with all the required reagents is operated by an integrated solar panel and a power pack.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Health 2 Leading Ebola Vaccines Appear Safe, Further Tests Starting

ASSOCIATED PRESS  by Maria Cheng                                                                          Jan. 9, 2015
LONDON --The World Health Organizationsays the two leading Ebola vaccines appear safe and will soon be tested in healthy volunteers in West Africa.

After an expert meeting this week, WHO said there is now enough information to conclude that the two most advanced Ebola vaccines ? one made by GlaxoSmithKline and the other licensed by Merck and NewLink ? have "an acceptable safety profile."

In a press briefing on Friday, Dr. Marie-Paule Kieny, who heads WHO's Ebola vaccine efforts, said "the cupboard (for Ebola vaccines) is filling up rapidly."

She said further trials in healthy people in West Africa, including health workers, are scheduled to start soon. Kieny added several other vaccines were being developed in the U.S., Russia and elsewhere.

Read complete story.
http://abcnews.go.com/Health/wireStory/leading-ebola-vaccines-safe-tests-starting-28107527

Problem, Solution, SitRep, or ?: 

IMF to provide new funds to help three main Ebola-hit nations

REUTERS   by James Harding Giahyue                                                  Jan. 8, 2015

The International Monetary Fund is preparing around $150 million in additional support to Liberia, Sierra Leone and Guinea, the countries at the heart of the Ebola epidemic, the Fund's representative in Liberia told Reuters on Thursday.

"In Guinea and Sierra Leone, existing Fund financial programs are being augmented to provide more resources to these countries. In Liberia, a one-off disbursement under the Fund's Rapid Credit Facility is being considered," Charles Amo-Yartey told Reuters in an email.

The money could be made available in the first quarter of this year and would add to $130 million disbursed by the Fund in September.

Read complete story.

http://www.reuters.com/article/2015/01/08/health-ebola-imf-idUSL6N0UN3RA20150108

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Geographic information helps provide public health intelligence at mass gatherings

MEDICALNEWS TODAY                                                            Jan. 6, 2015

Infectious diseases are one of the many health issues that worry the organizers of mass gatherings, such as the Hajj and the World Cup. Geographers' tools of the trade can help event organizers to better plan, monitor and respond timely to such eventualities. The ways in which geographers gather, analyze, and visualize information provide health officials with clearer pictures of the transport routes and environmental factors that may further the spread of viruses to and from the attendees' home countries.

In Chapter 3 of the new book Health, Science and Place: A New Model, geographer and biologist Dr. Amy Blatt explains how geographic information is used for disease surveillance at mass gatherings.
Read complete article

http://www.medicalnewstoday.com/releases/287577.php?tw

Read excerpt from the book,chapter 3.

by Dr. Amy Blatt
http://link.springer.com/chapter/10.1007%2F978-3-319-12003-4_3

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

What providers can learn from infectious disease outbreaks

FIERCEHEALTHCARE                 by                                                                Jan. 5. 2015

(Two items. Scroll down.)

With the Ebola crisis far from over as a new year begins, both this current threat to global health as well as past infectious disease outbreaks carry important lessons for critical care providers, according to an article in the American Journal of Critical Care.

Because new pathogens are so unpredictable, "outbreaks reinforce the importance of critical care knowledge, skill and teamwork in uncertain situations," wrote Cindy L. Munro, R.N., Ph.D., and Richard H. Savel, M.D, both editors of the AJCC. "The recent Ebola outbreak reminds us that hand-washing, personal protective equipment and pristine technique are essential."

Problem, Solution, SitRep, or ?: 

The Race for the Ebola Vaccine

THE DAILY BEAST  by Abby Haglage                                                                  Jan. 7, 2015

...Although a few smaller companies have become involved in the race for a vaccine, three major pharmaceutical makers are taking the lead—each pursuing a different vaccine. The trials are unprecedented for a variety of reasons, including the rapid timeline (trials of this nature generally take three to four years).

                                                      Steve Parsons-WPA Pool/Getty Images

Each individual race involves an unusual collaboration between researchers, manufacturers, and public-health entities. Together, the teams are working 24 hours a day for a product that promises much higher risk than it does profit.

Here’s what you need to know about the Ebola vaccine front-runners.

Read complete story.

http://www.thedailybeast.com/articles/2015/01/07/the-race-for-the-ebola-vaccine.html

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

J&J, Bavarian Nordic start clinical tests in Ebola vaccine race

REUTERS     by Ben Hirschler                              Jan. 6, 2015
LONDON --Johnson & Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing.

The initiation of the Phase I study in Britain, which had been expected about now, marks further progress in the race to develop a vaccine against a disease that has killed more than 8,000 people in West Africa since last year.

Two other experimental vaccines, one from GlaxoSmithKline and a rival from NewLink and Merck, are already in clinical development. However, the J&J vaccine offers a different approach, since it involves two separate injections.

Read complete story.

http://www.reuters.com/article/2015/01/06/us-health-ebola-vaccine-j-j-idUSKBN0KF0HH20150106

Problem, Solution, SitRep, or ?: 

Merck-NewLink Ebola vaccine trial resumes at lower dose: Geneva hospital

(Two stories. Scroll down.)

REUTERS                                                       Jan. 5, 2015

GENEVA --The clinical trial of an Ebola vaccine developed by Merck and NewLink resumed on Monday at a lower dose after a pause to assess complaints of joint pains in some volunteers, the University of Geneva hospital said.

The Geneva hospital announced on Dec. 11 that its vaccine trial had been suspended as a precautionary measure after four patients complained of joint pains. On Monday, the hospital said 10 of 59 volunteers who received the vaccine had felt pains in their joints "similar to rheumatism" after some two weeks, but these symptoms had disappeared rapidly without any treatment.

Swissmedic, the Swiss regulatory agency, and ethics and safety committees have approved the resumption of the trial at a lower dose, the hospital said in a statement.

Read complete story.

http://www.reuters.com/article/2015/01/05/us-health-ebola-vaccine-idUSKBN0KE0XP20150105
-0-
Read related announcement.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Solutions
howdy folks